Skip to main content

Advertisement

SpringerLink
Log in

Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

A number of mediators are involved in the inflammatory processes that affect joints and vascular wall of patients with rheumatoid arthritis (RA). Tumour necrosis factor alpha (TNFa) is one such mediator, and it is widely regarded as an important target for anti-rheumatic treatment. Most recent studies show that anti-TNFa medication suppresses inflammation and reduces overall activity of RA. The aim of the current study was to investigate changes of mean platelet volume (MPV) in response to the 3-month anti-TNFa therapy in RA. Twenty-one RA patients without established cardiovascular disease were recruited for anti-TNFa therapy and underwent thorough clinical and laboratory evaluation at baseline, 2 weeks, and 12 weeks. Anti-TNFa therapy resulted in a significant (p = 0.01) increase in MPV over the duration of the study (7.7 ± 0.9, 7.8 ± 1.1, and 8.4 ± 1.1 fL at baseline, 2 weeks, and 12 weeks, respectively). The results of the study expand perspectives of the use of MPV in conditions associated with high-grade inflammation, particularly RA, for monitoring anti-inflammatory treatment. More prospective studies with large numbers of patients are warranted to ascertain associations of high and low values of MPV with diverse markers of inflammation and vascular pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kitas GD, Erb N (2003) Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 42:607–613

    Article  CAS  Google Scholar 

  2. Douglas KM, Pace AV, Treharne GJ, Saratzis A, Nightingale P, Erb N, Banks MJ, Kitas GD (2006) Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 65:348–353

    Article  CAS  PubMed  Google Scholar 

  3. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732

    Article  PubMed  Google Scholar 

  4. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, Kitas GD (2008) Hypertension in rheumatoid arthritis. Rheumatology 47:1286–1298

    Article  CAS  PubMed  Google Scholar 

  5. Toms TE, Symmons DP, Kitas GD (2010) Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol, 1 Jan 2010 [Epub ahead of print]

  6. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, Jamurtas AZ, Kita M, Koutedakis Y, Kitas GD (2009) Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 68:242–245

    Article  CAS  PubMed  Google Scholar 

  7. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Treharne GJ, Panoulas VF, Douglas KM, Koutedakis Y, Kitas GD (2008) Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) 47:239–248

    Article  CAS  Google Scholar 

  8. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD (2002) Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 1:338–347

    Article  CAS  PubMed  Google Scholar 

  9. Emery P, Gabay C, Kraan M, Gomez-Reino J (2007) Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 27:793–806

    Article  CAS  PubMed  Google Scholar 

  10. Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Béchir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Lüscher TF, Gay S, Ruschitzka F (2002) Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106:2184–2187

    Article  PubMed  Google Scholar 

  11. Wolfe F, Michaud K (2004) Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 116:305–311

    Article  PubMed  Google Scholar 

  12. Chung I, Choudhury A, Lip GY (2007) Platelet activation in acute, decompensated congestive heart failure. Thromb Res 120:709–713

    Article  CAS  PubMed  Google Scholar 

  13. Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M (2008) Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 31:175–179

    Article  CAS  PubMed  Google Scholar 

  14. Arvidson NG, Larsen A, Aaseth J, Larsson A (2007) Short-term effects of the TNFalpha antagonist infliximab on the acute phase reaction and activities of daily life in patients with rheumatoid arthritis. Scand J Clin Lab Invest 67:337–342

    Article  CAS  PubMed  Google Scholar 

  15. Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, Martin J, Dessein PH, Llorca J (2008) Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol 26:311–316

    CAS  PubMed  Google Scholar 

  16. Milovanovic M, Nilsson E, Järemo P (2004) Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 343:237–240

    Article  CAS  PubMed  Google Scholar 

  17. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75:291–294

    Article  PubMed  Google Scholar 

  18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  CAS  PubMed  Google Scholar 

  19. National Institute of Clinical Excellence (2007) Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis. http://www.nice.org.uk/nicemedia/pdf/TA130guidance.pdf

  20. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  CAS  PubMed  Google Scholar 

  21. Dastjerdi MS, Emami T, Najafian A, Amini M (2006) Mean platelet volume measurement, EDTA or citrate? Hematology 11:317–319

    Article  PubMed  Google Scholar 

  22. Caporali R, Pallavicini FB, Filippini M, Gorla R, Marchesoni A, Favalli EG, Sarzi-Puttini P, Atzeni F, Montecucco C (2009) Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal. Autoimmun Rev 8:274–280

    Article  CAS  PubMed  Google Scholar 

  23. Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J (2006) Cardiovascular disease in rheumatoid arthritis. Biomed Pharmacother 60:673–677

    Article  CAS  PubMed  Google Scholar 

  24. Buttarello M, Plebani M (2008) Automated blood cell counts: state of the art. Am J Clin Pathol 130:104–116

    Article  PubMed  Google Scholar 

  25. Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157–161

    Article  CAS  PubMed  Google Scholar 

  26. Bath P, Algert C, Chapman N (2004) Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35:622–626

    Article  PubMed  Google Scholar 

  27. Yilmaz MB, Cihan G, Guray Y, Guray U, Kisacik HL, Sasmaz H, Korkmaz S (2008) Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 26:49–54

    Article  PubMed  Google Scholar 

  28. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478

    Article  CAS  PubMed  Google Scholar 

  29. Boos CJ, Beevers GD, Lip GY (2007) Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high-risk’ patients with hypertension. Ann Med 39:72–78

    Article  PubMed  Google Scholar 

  30. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A (2007) Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 120:245–250

    Article  CAS  PubMed  Google Scholar 

  31. Coban E, Afacan B (2008) The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 19:111–114

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Clinical Research Unit, Russell’s Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, West Midlands, DY1 2HQ, UK

    Armen Yuri Gasparyan, Aamer Sandoo, Antonios Stavropoulos-Kalinoglou & George D. Kitas

  2. Arthritis Research Campaign (ARC) Epidemiology Unit, University of Manchester, Manchester, UK

    George D. Kitas

Authors
  1. Armen Yuri Gasparyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aamer Sandoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonios Stavropoulos-Kalinoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George D. Kitas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Armen Yuri Gasparyan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gasparyan, A.Y., Sandoo, A., Stavropoulos-Kalinoglou, A. et al. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol Int 30, 1125–1129 (2010). https://doi.org/10.1007/s00296-009-1345-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1345-1

Keywords

Search

Navigation